Canopy Growth Corp. (WEED.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Canopy Growth Corp. (WEED.TO)

1.32

+0.01 (0.76%)

as of Jun 26, 2026, 8:00:00 pm Market Open.

251 watching

Investor Insights

Jun 27, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

Canopy Growth Corp. has drawn criticism from experts regarding its performance in the cannabis industry. One notable review highlights the company's weak returns on capital, which raises concerns about the substantial capital that has been reportedly invested and subsequently destroyed. The expert suggests that the cannabis sector lacks the necessary regulatory improvements and market stability, which hinders investment decisions. Additionally, there seems to be a call for major consolidation within the industry to enhance the operational efficiency and overall viability of companies like Canopy Growth. Consequently, investors are advised to approach this stock cautiously until the market improves significantly.

Consensus

Negative

Valuation

Overvalued

Similar

Aurora,ACB

DON'T BUY

After all the hopes and dreams it turned out to be a 'sell on news' type of thing. The space has been a bit of a disaster. He does not think he is short this one but it is not a space he is keep on.

PAST TOP PICK

(A Top Pick Dec 17/18, Up 30%) The covered call expired in July, which is why his returns were high. The stock has since plummeted with lots of challenges and changes in administration. If you did the option, then you did get the maximum amount and he got lucky.

DON'T BUY

He would not touch any of the cannabis stocks. They simply do not trade on any meaningful valuation metric. Even the big players do not know when they are going to become profitable. There are too many participants and there is no brand recognition yet.

DON'T BUY

She does not own stocks in the cannabis space. It is still too early to know how rules will unfold. Legalizing has not eliminated the black market, due to the price differential. She would consider this more a short term trade rather than a long term hold.

TOP PICK

He thinks the cannabis business is going to be one of the fastest growing over the next decade. WEED-T is leading the way. This year the market was challenging. The sell off will be done with tax loss selling as people focus on some of the new products. (Analysts’ price target is $28.23)

DON'T BUY

The whole sector was the go to sector, and now it's going in the other direction. Has lots of cash on the balance sheet, but losing money hand over fist. Whole sector has more downside, so avoid it, at least until the end of the year. Little fundamental support. Be very careful in this space.

SELL

If you're only down 10-15%, that's not so egregious, but there will be some tax loss selling into the end of the year. They'll have difficulty for the next 2 months. He'd probably step aside now, and look again in January.

DON'T BUY

This and three other cannabis stocks report tomorrow. He doesn't touch this sector--too uncertain. Regulation is still in flux. Edibles are legal, but not on the shelves. Governance has been terrible with Canopy with the CEO fired. Maybe under $15 you can defend this stock. Maybe there'll be fireworks with tomorrow's report. Avoid this sector.

DON'T BUY

He has been negative about cannabis stocks from day one. Yes, he missed the speculative run up, but he has avoided the down run as well. The sector is still in the first inning -- it is too early to know who will be the dominant players. Other sin stock sectors, like tobacco and alcohol, there are only a few large key players. When he can predict sales, earnings, cash flows then he will be willing to invest. The short term outlook looks scary as locked-in stock will be flooding the market soon. The hype is just too much. Stay away.

DON'T BUY

He is not in the cannabis space. There are too many players. It is like the auto market back in the early 1990s, when everyone was making cars. There will be a huge consolidation ahead. Maybe WEED-T is one that will survive. This is just not an investing environment.

BUY

The last 8 times it sold off and recovered. Its average decline was 42% and now around 47%. It's attractive now and the sector should show positive performance soon. Canopy remains the leader and should lead in derivative products starting in January 2020. If you want to enter cannabis with one stock, this is it.

DON'T BUY

Avoid. Tough sector, as it's unproven. Economics haven't been figured out. Revenues good, profits weak. Still tough to tell who the winners will be. A commodity has global competition. Too speculative. Unlikely that Constellation Brands will put more money in right now, but they will try to exert more influence.

COMMENT

It's one of the best weed stocks. He's invest a bit in this. They're large enough to endure problems that smaller ones have. But he needs to understand who the manager are--that determines their long-term prospects.

COMMENT

Investors are starting to see the books of the weed stocks. This is a show-me stock, but WEED is the bellweather, the big one. $60 will be a short-term top. The chart goes back to only 2018 though.

COMMENT

The push out of a senior executive, Bruce Linton, at WEED-T is a good signal for the company he thinks. There was not damage done by the Exec and he has done well personally by the agreement and is off the Board as well. This gives the Exec a great opportunity to sell his shares at a great value. The company has a $40 billion market cap. Constellation Brands had to take a charge against their $5 billion investment. Right now, Norman believes this is not an investable space yet -- the real leaders have not yet emerged. He expects further shake-outs in the space to come. There is no real brand recognition today.

Showing 16 to 30 of 125 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Canopy Growth Corp. (WEED.TO)